Free Trial

MNI BRIEF: UK Regulator Approves Pfizer/BioNTech Vaccine

Policy - Medical

The Covid-19 vaccine developed by BiONtech and Pfizer has been approved for use in the Medicines and Healthcare Regulatory Agency, the UK regulator, with their recommendation accepted by the government. The vaccine will be rolled out for use from December 7 -- or very shortly after.

Health Secretary Matt Hancock said Wednesday that up to 10 million doses will be available in the UK soon, with the first batch due within days. ''The NHS stands ready to start vaccinating early next week,' Hancock said via Twitter.'

MNI London Bureau | +44 203-865-3812 | les.commons@marketnews.com
True
MNI London Bureau | +44 203-865-3812 | les.commons@marketnews.com
True

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.